<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The clinical importance of the J-point elevation on electrocardiogram is controversial </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To study intracardiac J-point amplitude before <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Baseline 12-lead electrocardiogram and far-field right ventricular intracardiac implantable cardioverter-defibrillator electrograms were recorded at rest in 494 patients (mean age 60.4 ± 13.1 years; 360 [72.9%] men) with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> (278 [56.3%] ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>) who received primary (463 [93.9%] patients) or secondary prevention implantable cardioverter-defibrillator </plain></SENT>
<SENT sid="3" pm="."><plain>Ten-second intracardiac far-field electrograms before the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> were compared with the baseline </plain></SENT>
<SENT sid="4" pm="."><plain>The J-point amplitude was measured on the baseline 12-lead surface electrocardiogram and the intracardiac far-field electrogram </plain></SENT>
<SENT sid="5" pm="."><plain>The relative J-point amplitude was calculated as the ratio of J-point amplitude to peak-to-peak R-wave </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The paired t test showed that the relative intracardiac J-point amplitude was significantly higher before polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>/<z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) <z:hpo ids='HP_0003674'>onset</z:hpo> (0.28 ± 0.08 vs -0.19 ± 0.39; P = .012) than at baseline </plain></SENT>
<SENT sid="7" pm="."><plain>In a mixed-effects logistic regression model, adjusted for multiple episodes per patient, each 10% increase in relative J-point amplitude increased the odds of having <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> by 13% (odds ratio 1.13 [95% confidence interval 1.07-1.19]; P &lt; .0001) and increased the odds of having polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> by 27% (odds ratio 1.27 [95% confidence interval 1.11-1.46]; P = .001) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The relative intracardiac J-point amplitude is augmented immediately before the <z:hpo ids='HP_0003674'>onset</z:hpo> of polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in patients with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> </plain></SENT>
</text></document>